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Controllable synthesis of biomimetic
nano/submicro-fibrous tubes for
potential small-diameter vascular grafts†
Yizao Wan, ab Shanshan Yang,a Mengxia Peng,a Miguel Gama,c Zhiwei Yang, a
Xiaoyan Deng,ad Jianye Zhou, e Chenxi Ouyangf and Honglin Luo *ab
Mimicking the morphological structure of native blood vessels is critical for the development of vascular
grafts. Herein, small-diameter composite vascular grafts that integrate the nanofibrous bacterial cellulose
(BC) and submicrofibrous cellulose acetate (CA) were fabricated via a combined electrospinning and
step-by-step in situ biosynthesis. Scanning electron microscopy (SEM) observation shows the nano/
submicro-fibrous morphology and well-interconnected porous structure of the BC/CA grafts. It is found
that the BC/CA graft with a suitable BC content demonstrates lower potential of thrombus formation
and enhanced endothelialization as compared to the BC and CA counterparts. Western blotting and
RT-qPCR results suggest that the BC/CA-2 graft promotes endothelialization by improving expressions
of genes vWF-1 and CD31 and protein CD31. The in vivo tests demonstrate much lower inflammatory
response to the BC/CA graft. These results suggest that the BC/CA graft shows a great potential as an
artificial graft for rapid formation of an endothelial cell monolayer.
Introduction
Currently, autologous grafts (autografts) are still the gold
standard for vascular replacement. However, the use of auto-
grafts is limited by the shortage of donors and secondary site
injury.1,2 Therefore, artificial grafts have become the focus of
research in the field of vascular replacement. Although large
vascular grafts are successfully used in the clinic, small-
diameter vascular grafts (o6 mm) remain a huge challenge
due to intimal hyperplasia and thrombosis.1,3–6 Therefore,
much effort has been made to mitigate these issues, including
surface modification and controlled drug release approaches.7–9
Despite these achievements, the performance of the reported
small-diameter vascular grafts is still unsatisfactory. Accordingly,
new strategies are highly demanded to develop novel small-
diameter grafts with rapid endothelialization and therefore
non-thrombotic.10
Recently, mimicking the morphological structures of native
tissues becomes a popular strategy. Native blood vessels
are composed of three layered structures, i.e., tunica intima,
tunica media, and tunica adventitia.11,12 Of these three layers,
replicating the structure of tunica intima is the focus of
research on vascular grafts, which contains a monolayer of
endothelial cells attached to their basement membrane, and is
critical to anti-thrombosis.3,6 The basement membrane in tunica
intima is composed of a topographically rich three-dimensional
(3D) non-woven porous fibrous network in which the fibers are
on the nano (1–100 nm) and submicron (100–1000 nm) size
scale. The intrinsic topography of the basement membrane plays
a critical role in adjusting the adhesion, migration, proliferation,
and differentiation of the overlying endothelial cells.13 Although
a great deal of research has been emphasized on the fabrication
of nano/micro-fibrous14,15 and nano/submicro-fibrous16,17 scaf-
folds, nano/submicro-fibrous vascular grafts have not yet been
reported. Furthermore, many studies focused on the fabrication
of structurally biomimetic vascular grafts including bi-layered
structures10,18 and tri-layered grafts.11 The replication of the
nano/submicro-fibrous structure of the tunica intima has not
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been reported, partially because it is difficult to integrate nanofibers
and submicrofibers within a hollow tube by available techniques.
Herein, bacterial cellulose (BC) was used as the nanofibrous
component due to its intrinsic nano-scale fiber diameter
(20–100 nm) and great potential as vascular grafts.19–25 To this
end, we combined BC nanofibers with electrospun submicrofibers
of cellulose acetate (CA) to produce tubular grafts using an in-house
setup. The main objectives of this work are thus to prepare the
nano/submicro-fibrous vascular grafts with varying contents of BC,
to evaluate their morphologies, chemical and mechanical proper-
ties, in vitro and in vivo biocompatibility, the propensity of the
material for endothelialization, and to understand how endothelial
cells respond to the nano-submicro-fibrous matrix.
Experimental procedure
Materials
The materials for BC biosynthesis including yeast extract,
tryptone, disodium phosphate (Na2HPO4), and acetic acid were
provided by Beijing Innochem Science & Technology Co., Ltd,
China. All other materials and reagents were purchased from
Tianjin Kemiou Chemical Reagent Co., Ltd, Tianjin, China,
unless otherwise indicated and used as received without any
further purification. The bacterial strain, Komagataeibacter
xylinus X-2, was received from Tianjin University of Science
and Technology, Tianjin, China.
Preparation of electrospun CA submicrofibrous graft
Cellulose acetate (CA, MW = 4.0  104) was dissolved into a
mixture of acetone/acetic acid (1/1 by volume) under constant
stirring, resulting in a CA solution with a concentration of
15 wt%. The CA solution was poured into a 10 mL plastic
syringe and fed by a pump through a stainless steel needle. The
electrospinning was performed at a voltage of 10 kV, a solution
flow rate of 5 mL h1, and a throw distance (between collector
and needle) of 15 cm (at approximately 25–30 1C) and 40%
relative humidity. The fibers were directly collected on a cylinder
rotating at 100 rpm (Fig. 1A) with a diameter corresponding to
Fig. 1 Preparation of nano/submicro-fibrous BC/CA tubular grafts. (A) Electrospinning was used to generate a tubular submicrofibrous scaffold on top
of a rotating cylinder. (B) BC nanofibers in situ grew into the pores within the tubular CA scaffold that serves as a template. (C) The nano/submicro-fibrous
hydrogels were cleaned, yielding nano/submicro-fibrous tubular grafts with different diameters. (D) A schematic diagram illustrating the morphological
structure of the nano/submicro-fibrous tubular grafts.
Paper Journal of Materials Chemistry B
View Article Online
5696 | J. Mater. Chem. B, 2020, 8, 5694--5706 This journal is©The Royal Society of Chemistry 2020
that of the envisaged graft. The obtained submicrofibrous CA
graft was vacuum dried at 70 1C for 24 h and finally sterilized at
115 1C for 30 min.
Preparation of nano/submicro-fibrous BC/CA grafts
The bacterial strain, Komagataeibacter xylinus X-2 was used for
the production of BC, and the culture medium (pH = 4.5) for
the fermentation consisted of 2.5% (w/v) glucose, 0.75% (w/v)
yeast extract, 1% (w/v) tryptone, and 1% (w/v) Na2HPO4. As
illustrated in Fig. 1B, two silicon tubes with different diameters
were fixed in the assembly, and the space between them was
filled with the culture medium (150–200 mL) inoculated with
the bacteria. There was sufficient oxygen due to the existence of
the vent hole and the silicon tubes. A BC ring (BC substrate)
with a thickness of about 2 mm could be obtained after culture
for 1–2 days within the space, which was used as the substrate
for the preparation of BC/CA grafts via the step-by-step in situ
biosynthesis as reported in our previous studies.26 Typically, a
tubular CA scaffold 30 mm long was cut and placed on the top
of the BC substrate. The culture medium (50 mL) was sprayed to
the space between silicon tubes, thus filling the pores of the CA
scaffold. After in situ growth of BC within the CA scaffold for
1 h, a second cycle of feeding and growth continued. The process
was completed after the 4th cycle, yielding the BC/CA-1 hydrogel.
Similarly, BC/CA-2, BC/CA-3, and BC/CA-4 hydrogels were pro-
duced, corresponding to 6, 8, and 10 cycles, respectively. The same
procedure was employed to produce a bare BC graft for control.
Afterward, the BC/CA hydrogels were taken out and purified using
the same procedures reported in our previous work,27 leading to
BC/CA grafts with varying diameters (Fig. 1C). The diameter and
thickness of the BC/CA grafts were determined by the diameter of
the two silicon tubes and the space between them. The morpho-
logical structure of the BC/CA grafts is illustrated in Fig. 1D. BC
and BC/CA grafts were immersed in tertiary butanol for 10 h,
renewed every 2 h, followed by washing with deionized water at
least three times, for further characterization. The grafts were
stored in a freezer at 20 1C for 24 h and finally lyophilized at
50 1C for 36 h to obtain the BC and BC/CA aerogels.
Characterizations
The digital photographs were taken with a Canon DS126431
digital camera. The morphologies of BC, CA, and BC/CA grafts
(in aerogels) were observed with a scanning electron micro-
scope (SEM SU8010, Hitachi, Japan). The fiber diameter was
determined by measuring at least 100 randomly selected fiber
segments from SEM images using the Nano Measurer 1.2
software, as reported in our previous work.26,28 To determine
the crystalline structure of graft materials, X-ray diffraction
(XRD) analysis was carried out with a Rigaku D/max 2500
X-ray diffractometer using Cu Ka radiation (l = 0.154 nm;
Shimadzu, Japan). The samples were scanned from 101 to 401
at a scan speed of 0.021 s1. The morphologies were also
observed with atomic force microscopy (AFM) using a NT-MDT
Ntegra Prima scanning probe microscope operating in the
contact mode (Ntegra Prima KFM, NT-MDT, Russia). Thermo-
gravimetric analysis (TGA) was conducted using a Diamond
TG/DTA machine (DTG-60AH, Shimadzu, Japan) by heating
10–15 mg of samples from 30 1C to 600 1C at 20 1C min1
under a N2 flow of 100 mL min
1. The static water contact angle
was measured using a Drop Master 300, to characterize the
hydrophilicity of the grafts (after pressing at room temperature).
Tensile test was conducted using a micro-electromagnetic fatigue
testing machine (MUF-1050, Tianjin Care Measure & Control Co.,
Ltd, Tianjin, China) with rectangular samples (10  5  2 mm3)
at a strain rate of 5 mm min1. The contents of BC in BC/CA grafts
were determined by weighing the dry weight of the CA and BC/CA
samples using an electronic balance.
Platelet adhesion
Fresh platelet rich plasma (PRP) was obtained from rabbits.
The blood was centrifuged at 1500 rpm for 15 min to obtain
PRP supernatant. The BC, CA, and BC/CA samples were cut into
circular specimens with a diameter of 15 mm and placed into
24-well culture plates. 100 mL of PRP was carefully deposited
on each specimen followed by incubation at 37 1C for 1 h.
After washing with PBS solution, these treated specimens were
fixed using 0.25% glutaraldehyde solution for 24 h and then
dehydrated with a series of ethanol solutions (30, 50, 75, 90,
100%) for 15 min each. Finally, the dehydrated specimens were
air-dried and sputter-coated for SEM observation.
The platelet adhesion on BC, CA, and BC/CA grafts was also
quantified by a lactic acid dehydrogenase (LDH) release assay.
In brief, fresh PRP (300 mL) was dropped on BC, CA, and BC/CA
grafts, respectively, and incubated at 37 1C for 2 h. The PRP
suspension was removed from samples, followed by washing
with PBS for three times. The lysis solution (150 mL) was then
dropped on the grafts and incubated at 37 1C for 1 h to induce
lysis of the adhered platelets and LDH release. The lysate
(120 mL) was collected and mixed with the substrate solution
(80 mL). Finally, the mixtures were centrifuged at 4000 rpm for
5 min and the supernatants were collected and measured
at 490 nm using a microplate reader (2000, Thermo Fisher,
Waltham, USA).
Hemolysis rate determination
The hemolysis rate was tested using healthy rabbit blood,
which was diluted with phosphate buffer saline (PBS) solution
with a volume ratio of 4/5 (rabbit blood/PBS). Each circular
sample with a diameter of 10 mm was put into a tube containing
10 mL of 0.9% (w/v) sodium chloride solution and conditioned
at 37 1C for 30 min. Afterward, 0.2 mL of the diluted blood was
added followed by incubation at 37 1C for 1 h. Finally, the
solutions were centrifuged at 3000 rpm for 5 min and the
supernatant was measured at 540 nm using the aforementioned
microplate reader to determine the optical density (OD). The
hemolysis rate was calculated using eqn (1).29
R = (A  C1)/(C2  C1)  100% (1)
where R was the hemolysis ratio (%), A was the absorbance (%),
C1 and C2 were the absorbance of the negative and positive
controls (%), respectively.
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In vitro biocompatibility
The cell proliferation was evaluated by Cell Counting Kit-8
(CCK-8) assay using human umbilical vein endothelial cells
(HUVEC, Shanghai Ninth People’s Hospital). The HUVEC cells
were cultured in endothelial cell medium (ENCM) supplemented
with 10% fetal bovine serum (FBS) and 1% ECGS in a humidified
incubator with 5% CO2 at 37 1C. The culture medium was
renewed every other day. The circular grafts with a thickness of
1 mm and a diameter of 14 mm were sterilized at 121 1C for
30 min (LDZX-30KBS, Shenan, Shanghai, China). Prior to cell
seeding, grafts were immersed in medium with 10% FBS at 37 1C
for at least 3 h. Afterward, cells were seeded on the grafts with a
density of 1  104 per well and incubated at 37 1C in a 5% CO2
incubator for 1, 4, and 7 days. After incubation, 200 mL of mixed
medium containing CCK-8 and ENCM (VCCK-8 : VENCM = 1 : 10)
was added to each well followed by incubation in darkness
at 37 1C for 3 h. The culture medium (100 mL) was transferred
to 96-well plates and the absorbance was read at 450 nm using
microplate reader (iMark, Bio Rad, California, USA).
After culture under the aforementioned conditions, the grafts
were rinsed with PBS (phosphate buffered saline) twice followed
by staining with live staining reagent (Fluorescein diacetate). After
further incubation for 30 min, the stained cultures were viewed
using a fluorescence microscope (TS2, Nikon, Tokyo, Japan).
The cell morphology was observed by SEM. After incubation
for 4 and 7 days at 37 1C in a humidified atmosphere containing
5% CO2, cells were fixed with 2% glutaraldehyde solution at 4 1C
for 12 h, and dehydrated in a graded series of ethanol (50, 60, 70,
80, 90, 95, and 100%). The cell samples were coated with a thin
layer of gold, and observed under SEM.
Western blotting
The Western blotting assay was conducted as reported in our
previous work.16 Briefly, cells were seeded on grafts for 3 days
followed by the removal of the culture medium and washing with
PBS three times. Trypsin was added to digest the cells on grafts and
transferred to epoxy tube followed by centrifugal washing with PBS.
Afterward, 100 mL of protein lysate containing protease inhibitor
(PMSF) was added to lyse the cells on the ice. The total protein
concentration in the lysate was measured with BCA kit and adjusted
to 1 mg mL1 by adding different volumes of 1  and 5  loading
buffers. Proteins of different molecular weights were separated with
SDS-PAGE gel electrophoresis and transferred onto a PVDF
membrane. The membrane was treated with 5% skimmed milk
blocking buffer at 37 1C for 1 h and then with diluted rabbit-derived
CD31 antibody (bs-04689R, Bioss, China) and mouse-derived
GAPDH (ABA0036, Abway, China) solution (1 : 1000) separately over-
night at 4 1C. Thereafter, the membrane was washed with TBST
(0.01% Tween-20 in TBS) for three times and 5 min each time, which
was then incubated with goat anti-rabbit and goat anti-mouse
second antibodies (Jackson, Hartford, USA) for 1 h at room tem-
perature. The ECL plus Western blotting substrate was used to
visualize the protein bands. The pictures were obtained with Tanon
Imager (5200, Tianneng Co., Ltd, Shanghai, China) and band
intensity was measured with Image J.
Real time qPCR
RT-qPCR was used to analyze the expressions of von Willebrand
Factor 1 (vWF-1), CD31, and GAPDH as a housekeeping gene.
The circular-shaped films were placed inside the 24-well tissue
culture dish and HUVEC were seeded at 3.0  104 cells per well
with ECM in 6 well cell culture-plates. After 24 h, the media
were changed with ECM supplemented with FBS (10%)
and cultured for another 48 h. Total RNA was obtained from
these samples using Easteps Super Total RNA Extraction kit
(Promega, China), and reverse transcribed to cDNA by Hifairs
II 1st Strand cDNA Synthesis SuperMix (YEASEN, China). 400 ng
of cDNA was used for each PCR reaction with Hieffs qPCR
SYBR Green Master Mix (YEASEN, China) to determine
gene expression of (GAPDH: fw. TGGCGGGGAAGTCAGGT rev.
CATGTAAACCATGTAGTTGAGGTC, vWF-1: fw. TTCCCGACAA
GGTGTGTGTC rev. TCGCCTTCATGCAGAACGTA, CD31: fw.
ACGTGCAGTACACGGAAGTT rev. GGAGCCTTCCGTTCTAGAGT).
After an initial denaturation of the cDNA at 95 1C for 5 min, PCR
was performed for 40 cycles. Each cycle consisted of denatura-
tion at 95 1C for 10 s and primer annealing and primer exten-
sional for 30 s at 60 1C. Finally, a 5 min extension step at 60 1C
was performed. The 2-(DDCT) method was applied to calculate
relative quantification.
In vivo biocompatibility
The in vivo biocompatibility was tested by subcutaneous
implantation experiments. The animal experiments were con-
ducted in accordance with the ethical guidelines approved by
the Animal Use and Care Administrative Advisory Committee of
East China Jiaotong University. Twelve healthy Institute of
Cancer Research (ICR) rats (8-week-old, male, 20–25 g) were
selected and anesthetized with ethyl ether. BC, CA, and BC/CA-2
grafts (10 mm 10 mm) were sterilized with ethylene oxide and
then subcutaneously implanted into the back of rats. After
1 and 2 weeks, the rats were sacrificed and grafts were taken
out, fixed with 4% paraformaldehyde, embedded with paraffin,
and sliced for staining with hematoxylin and eosin (H&E),
Masson’s trichrome, and immunohistochemistry, separately.
Statistical analysis
All experiments were performed independently for at least five
times and the results were presented as mean value  standard
deviation (SD). Statistical analysis was performed using
SPSS software (version 20), and a one-way ANOVA with the
least-significant difference (LSD) post hoc was used to deter-
mine the presence of any significant differences between
different sample groups. Statistically significant differences
were accepted as p-value o0.05.
Results
Morphology and structure
Although electrospinning is a versatile method, it is difficult to
prepare a tubular biomimetic structure combining nano (tenths of
nm)/submicro (hundreds of nm)-fibers. Therefore, we developed
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a new fabrication procedure by combining electrospinning and
BC fermentation (Fig. 1D). The diameter of the tubular graft
can be as small as 1.0 mm (Fig. 1C). Furthermore, the ratio of
BC nanofibers to CA submicrofibers can be adjusted.
The morphologies of nano/submicro-fibrous grafts were
observed by SEM (Fig. 2A) and average fiber diameter was
determined (Fig. S1, ESI†). BC nanofibers with a diameter of
about 46–50 nm and CA submicrofibers with a diameter of
0.64–0.92 mm, are combined in an interpenetrated network.
Furthermore, BC nanofibers are present throughout the entire
BC/CA grafts, which can be confirmed in Fig. S2 (ESI†). As
shown in Fig. 2A, the number of BC nanofibers increases with
the biosynthesis duration (Table S1, ESI†). The AFM images in
Fig. 2B further show details of the combined BC nanofibers/CA
submicrofibers network.
XRD analysis was conducted for BC, CA, and BC/CA grafts
(Fig. 3A). As expected, BC shows three characteristic peaks at
14.61, 16.81, and 22.81, which correspond to the (1%10), (110),
and (200) diffraction planes of cellulose, consistent with pre-
vious studies.27,30,31 The XRD pattern of CA shows a broad peak
similar to a previously reported result.32 In addition to the
peaks assigned to BC, another one at about 201 is noted in the
XRD patterns of BC/CA grafts, similar to our previous result.16
However, the validation of this peak requires further investiga-
tion in the future.
The FTIR spectra of different samples are displayed in
Fig. 3B. Characteristic peaks at 3348 cm1, 2890 cm1, and
1061 cm1 are observed in the spectrum of BC, which corre-
spond to –OH bonds, asymmetric stretching vibration of C–H,
and anti-symmetric bridge stretching of C–O–C, respectively.33
In the FTIR spectrum of CA, O–H stretching at 3491 cm1, –CH2
asymmetric stretching at 2894 cm1, C–O–C stretching at
1052 cm1 are noted.34,35 The FTIR spectrum of CA also shows
O–H stretching at 3491 cm1, –CH2 asymmetric stretching at
2894 cm1, and C–O–C stretching at 1052 cm1.34,35 These
peaks are also seen in the spectra of BC/CA materials. Note that
the CQO in-plane stretching vibration at 1740 cm1 is also
observed in the spectrum of CA, which indicates the formation
of ester group as a result of acetylation reaction.36 However, this
peak is not detected in the spectra of BC/CA materials due to
acetate hydrolysis in alkaline medium during purification of
BC.35 Compared with CA, a significant red shift for –OH groups
is observed in BC/CA, due to the formation of hydrogen bond-
ing between BC and CA.26
Physical properties
Thermal stability of BC, CA, and BC/CA materials was deter-
mined (Fig. S3, ESI†). The TGA curves reveal a similar three-
stage trend—a slight weight loss below 100 1C due to water
evaporation,37 a drastic weight loss at 250–400 1C due to
degradation of main cellulose skeleton,38 and a stable stage at
higher temperatures. Moreover, the TGA result indicates a slight
positive effect of BC on the stability of the BC/CA materials.
Wettability is an important factor with great influence on
cell attachment.39,40 The water contact angles of BC, CA, and
BC/CA materials were tested and the results are presented in
Fig. S4 (ESI†). CA is hydrophobic with an average contact angle
of 121.21, but BC is hydrophilic with an average contact angle of
32.11. The contact angles of the BC/CA materials lie between
those of the BC and CA, ranging from 53.31 to 100.81.
The tensile stress–strain curves (Fig. 4A) show that the
maximum stress and strain at break are different. The quantitative
Fig. 2 (A) SEM images of BC, CA, and BC/CA grafts. Scale bar: 2 mm. (B) AFM images of BC, CA, and BC/CA-2 grafts.
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results of tensile strength, Young’s modulus, and strain at break
are shown in Fig. 4B–D. Note that CA shows the lowest tensile
strength (0.14  0.03 MPa) and Young’s modulus (1.09 
0.14 MPa), but the highest strain at break (38.56  1.38%). BC
exhibits a tensile strength of 0.95  0.12 MPa, which is higher
than that (0.38  0.1 MPa) reported by Xie et al.41 As shown in
Fig. 4B and C, adding BC to CA significantly increases the tensile
strength and Young’s modulus. Furthermore, BC/CA-2, BC/CA-3,
and BC/CA-4 show significantly higher tensile strength, Young’s
modulus and strain at break compared with BC ( p o 0.05 for
tensile strength and strain, and p o 0.01 for Young’s modulus).
In vitro characterization
Platelet adhesion and activation on a material’s surface may
induce thrombosis, and is thus of utmost importance in the
assessment of vascular grafts.42,43 In this work, SEM images of
platelets adhered on BC, CA, and BC/CA surfaces are presented
in Fig. 5A. The quantitative results are displayed in Fig. 5B and
the scheme showing the locations of platelets on BC/CA grafts
is illustrated in Fig. 5C. A large number of platelets adhere on
the surfaces of BC and BC/CA-4, partially showing irregular
morphology, aggregation, and widely spread shape, which may
indicate activation and potential for thrombus formation.44,45
The number of adherent platelets was quantified via the
LDH assay (Fig. 5B). Note that significantly fewer platelets are
observed on BC/CA-1 and BC/CA-2 as compared to BC/CA-3 and
BC/CA-4 ( p o 0.05). There is no significant difference in the
number of adhered platelets between BC/CA-1 and BC/CA-2,
and a few observed exhibit grainy shape without pseudopodia
or deformation (Fig. 5A), indicating that they are not activated.
Fig. 3 XRD (A) and FTIR (B) results of BC, CA, and BC/CA grafts.
Fig. 4 Mechanical properties of BC, CA, and BC/CA materials: (A) typical stress–strain curves, (B) tensile strength, (C) Young’s modulus, (D) strain at
break. Statistical significance was defined as *p o 0.05, **p o 0.01, n = 5. ns represents not significant, p 4 0.05.
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This result suggests that BC/CA-1 and BC/CA-2 grafts have good
hemocompatibility and anti-thrombogenic potential.
Blood contacting materials must be non-toxic for blood
cells. A high hemolysis rate means a large amount of break-
up of cell membranes, which accelerates clotting and thrombus
formation.43,46 A hemolysis rate below the threshold of 5%
means little harm to red blood cells,47 while a value of 0–2% is
classified as non-hemolytic according to the American Society
for Testing and Materials.48 Note that all BC/CA grafts have
lower hemolysis rates than BC, but higher than CA. Moreover,
As shown in Table 1, all grafts exhibit a hemolysis rate much
lower than 1%. The hemolysis rate of BC/CA-2 is 0.28%, which
is lower than those of the ePTFE vascular graft (0.9%) reported
by Chen et al.49 and an electrospun spider silk protein/PCL/
gelatin graft (0.3%) reported by Xiang et al.50
The formation of a complete endothelial layer on the surface
of vascular grafts is crucially important to enhance long-term
patency.45,51 Endothelialization was monitored in vitro by seed-
ing HUVECs onto BC, CA, and BC/CA grafts. The SEM images
(Fig. 6A) show increased cell coverage on all grafts when the
culture time increases from 4 to 7 days. At day 7, extensive
cell proliferation, spreading, and attachment are observed on
BC/CA-1 and BC/CA-2 grafts. Fig. 6B demonstrates quicker
endothelialization of BC/CA-1 and BC/CA-2 grafts than other
grafts.
The CCK-8 assay results further confirm these observations
(Fig. 6C). The difference in the cell viability among the grafts is
not significant after 1 day culture. At day 4, the proliferation
level is significantly higher on BC/CA-1 and BC/CA-2 as compared
to other grafts (p o 0.01). The same trend remains unchanged at
day 7. The biocompatibility was also evaluated by fluorescence
staining. Fig. S5 (ESI†) shows images of HUVEC cells seeded on BC,
CA, and BC/CA grafts. The amount of HUVEC cells continuously
increases with increase of culture time, suggesting robust prolifera-
tion on all grafts.
Taken together, hybridizing nanofibrous BC with submicro-
fibrous CA can potentially decrease the thrombosis, demon-
strating great potential for application in vascular grafts. To
further evaluate the performance of BC/CA grafts, BC/CA-2 was
Fig. 5 (A) SEM images of platelets adhered on BC, CA, and BC/CA grafts. Scale bar: 5 mm. (B) Quantification of adhered platelets measured by lactate
dehydrogenase (LDH) activity after incubation of the BC, CA, and BC/CA grafts in platelet-rich plasma (PRP). Significance was defined as *p o 0.05,
**p o 0.01, n = 5. ns represents not significant, p 4 0.05. (C) Illustration of platelets on BC/CA grafts.
Table 1 Hemolysis rate of BC, CA, and BC/CA grafts
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selected for Western blotting assay and in vivo biocompatibility
assessment, which exhibits improved mechanical properties
than BC/CA-1, and comparable in vitro biocompatibility, hemo-
lysis rate, and platelet adhesion and activation.
To further demonstrate the advantage of BC/CA grafts, the
expression of CD31 protein was assessed using the Western
blotting assay. The results shown in Fig. 7A and B reveals
the relative expression of CD31 (0.82  0.08) on BC/CA-2 is
1.6 times higher than BC (0.50  0.01), and is also significantly
higher than CA (0.72  0.06, p o 0.05).
The expressions of the HUVEC-specific markers, genes
vWF-1 and CD31, were examined at the mRNA level. As shown
in Fig. 7C, the relative expression levels of vWF and CD31
on BC/CA-2 are significantly higher than those on BC and CA
( p o 0.01).
In vivo biocompatibility evaluation
In vivo biocompatibility of materials can be evaluated by sub-
cutaneous implantation, which can demonstrate the degree
of inflammatory response and foreign body reaction.52 In
this work, BC, CA, and BC/CA-2 grafts were subcutaneously
implanted into rats for up to 2 weeks. The H&E staining images
in Fig. 8A reveal fewer inflammatory cells around the BC/CA-2
graft as compared to BC and CA grafts. The Masson’s trichrome
staining results (Fig. 8B) demonstrate a thinner fibrotic capsule
around BC/CA-2 graft as compared to BC and CA grafts. The
results of immunohistochemical DAB staining (Fig. 8C) pre-
sents that there are a large number of inflammatory cells of
CD8+ in the surrounding tissues of BC and CA grafts, while the
BC/CA-2 graft shows much fewer inflammatory cells, indicating
less rejection reaction of the BC/CA-2 graft than BC and CA grafts.
Fig. 6 (A) SEM images of HUVEC cells seeded on BC, CA, and BC/CA grafts for 4 and 7 days. Scale bar: 20 mm. (B) Area of endothelialization
counted by the area occupied by HUVEC cells. (C) CCK-8 assay results. Significance was defined as *p o 0.05, **p o 0.01, n = 5. ns represents not
significant, p 4 0.05.
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These results suggest that the BC/CA-2 graft has improved
in vivo biocompatibility over bare BC and CA grafts.
Discussion
An ideal small-diameter vascular graft should mimic the mor-
phology of native blood vessels. Native extracellular matrices
(ECMs) mainly consist of collagen fibrils that have a diameter
ranging from 50 (nanoscale) to 500 nm (submicron scale). Such
morphology is crucially important for cell adhesion and
proliferation.53–56 To this end, different techniques such as
electrospinning,57,58 thermally induced phase separation,59
melt spinning,60 self-leaching,61 and freeze drying,62 have been
developed to fabricate matrices with biomimetic morphology in
recent years. Among these methods, electrospinning is the
most widely used. However, it is not easy to fabricate fibers
with diameters down to the nanoscale (the lower limit of 50 nm
in natural ECMs).63,64 Mimicking the nano/submicro-fibrous
morphology of native blood vessels still remains a great challenge.
In this study, we developed morphologically biomimetic vascular
grafts composed of BC nanofibers and CA submicrofibers using a
combined method of electrospinning and step-by-step in situ
biosynthesis. We previously prepared nano/submicro-fibrous scaf-
folds for tissue engineering or cancer cell culture.16,17,65 Although
the nano/submicro-fibrous structure was mimicked, the BC/CA
ratio has not been modulated, which might affect the morphology,
mechanics and in vitro/in vivo biological behaviors of the BC/CA
grafts, particularly endothelialization. In this study, we can control
the BC/CA ratio by adjusting the in situ biosynthesis duration.
The result in Table S1 (ESI†) confirms that the content of BC
nanofibers varies from 2.7 to 9.1 wt% and more importantly
it affects the mechanical properties of the BC/CA grafts. All
BC/CA grafts except for BC/CA-1 exhibit significantly higher
tensile strength and Young’s modulus compared with bare BC
(p o 0.05), which, when used alone, has been reported as an
appropriate material for vascular graft.19–21,25 It is therefore
deduced that BC/CA-2, BC/CA-3, and BC/CA-4 have suitable
mechanical properties for vascular grafts.
SEM observation demonstrates that the fiber diameters of
BC nanofibers and CA submicrofibers are 46–50 nm and 0.64–
0.92 mm, respectively, which are comparable to the size range of
collagen fibers in native tissues. The diameter of fibers plays an
important role in the adhesion of the cells to the fibers.66,67
Previous in vitro experiments demonstrated that micron-sized
fibrous substrates could support human HUVEC monolayer
formation,68 while other studies suggested that small-diameter
fibers represent a better basis for endothelialization.69–71 For
instance, Milleret et al. claimed that thin fibers (diameter o
1 mm) triggered very low coagulation and few adhered platelets
while larger fiber diameter (2–3 mm) triggered higher thrombosis
formation and more adhered platelets.69 These findings
seemed to indicate that grafts with small fiber diameter could
reduce early thrombogenicity due to lower platelet adhesion and
activation. However, no report can be found in literature on the
use of ultra-thin (o100 nm) fibrous structure as vascular grafts
except for nanofibrous BC. It is noteworthy that although bare
BC grafts demonstrated good functions,19–25 the combination
Fig. 7 Western blot (A) and (B) and real-time quantitative PCR (C) after cell culture on BC, CA, and BC/CA-2 for 3 days. (A) Representative images
of Western blotting assay. (B) Relative expression of CD31 protein. (C) Relative expression levels of vWF-1 and CD31 genes. Significance was defined as
*p o 0.05 or **p o 0.01, n = 6 in each group.
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of BC nanofibers with submicrofibers as vascular grafts has not
yet been reported.
The activation of platelets is considered to be the first step of
thrombogenesis, compromising the patency of vascular grafts.72
As displayed in Fig. 5 and Table 1, the BC/CA-2 graft exhibits
lower platelet adhesion and hemolysis rate compared with the
other grafts, suggesting that improved hemocompatibility may
be achieved by optimizing the BC content.
As shown in Fig. 6A and B, endothelialization of the BC/CA-2
graft quickly occurs. Furthermore, Western blotting and RT-qPCR
results (Fig. 7) confirm the enhanced expressions of protein CD31
and genes CD31 and vWF-1 from BC/CA-2 samples as compared
to single BC and CA samples. CD31 is highly localized in
endothelial cell junctions for robust endothelialized structure.73
CD31 not only participates in the construction and maintenance
of a stable endothelial cell layer, but is also related to
Fig. 8 In vivo results from subcutaneous implantation of BC, CA, and BC/CA-2 grafts in the back of rats for 7 and 14 days. (A) H&E staining images of
samples: the nucleus was dyed blue-black; the color of the components in the cytoplasm and the extracellular matrix were red. (B) Masson’s trichrome
staining images of samples: collagen fibers and mucus are stained blue; muscle fibers, cellulose, and erythrocytes are stained red; the nucleus was dyed
blue-black. (C) DAB staining images of samples: CD8 positive stained brownish yellow; the nucleus was dyed blue-black. G. and T. represent grafts and
tissues, respectively. Scale bars: 100 mm.
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neo-vascularization and angiogenesis.74 It is believed that
vWF-1 is a vital predictor of endothelialization after graft
implantation in blood vessel.75 Therefore, together with the
in vitro endothelialization result, the Western blotting and
RT-qPCR results suggest that the BC/CA-2 graft can promote
endothelialization, and thus reduce formation of thrombosis
and increase patency.
Subcutaneous implantation into animals is important
for the evaluation of in vivo biocompatibility of materials
before in situ implantation. The results in Fig. 8 display lower
inflammatory response of BC/CA-2 as compared to bare BC
and CA. Therefore, both the in vitro (Fig. 6C) and in vivo
biocompatibility experiments confirm that the BC/CA-2 possesses
excellent biocompatibility, demonstrating great potential to be
used as vascular grafts.
The overall excellent performance of BC/CA-2 graft can be
explained as follows: (1) chemically, cellulose is believed to be
nonthrombogenic with low platelet adhesion and low coagula-
tion activation76 and more importantly BC has been confirmed
by many researchers to have great potential for vascular
grafts.19–25 (2) Mechanically, BC/CA-2 shows a higher tensile
strength than bare BC and is comparable to that of human
umbilical vein.77 (3) More importantly, morphologically, the
size of BC nanofibers is close to that of the lower limit of
collagen fibrils (50 nm) in native tissues and the CA submicro-
fibers show comparable size to that of the upper limit of native
collagen fibrils (500 nm), which means that the BC/CA-2
possesses biomimetic nano/submicro-fibrous morphology that
contributes to cell spreading and cell functions.78,79
Conclusions
The nano/submicro-fibrous BC/CA grafts with biomimetic
structure have been fabricated via a combined method of
electrospinning and modified in situ biosynthesis. The BC/CA
grafts show fibrous and interconnected porous structure with
nanofibers (46–50 nm) and submicrofibers (0.64–0.92 mm). The
mechanical properties of the nano/submicrofibrous BC/CA
grafts (except for BC/CA-1) are improved compared with CA
and BC grafts, due to the mechanical entanglement and hydro-
gen bonding between BC nanofibers and CA submicrofibers.
Endothelial cells actively spread with a higher density after
seeding on the surface of the BC/CA-2 graft for 7 days, compared
with BC/CA-3 and BC/CA-4 grafts, showing promotion of
endothelialization by the BC/CA-2 graft. The platelet adhesion
test demonstrates that fewer adhered platelets are observed on
the BC/CA-2 graft and the hemolysis assay result displays lower
hemolysis rate for the BC/CA-2 graft, compared with the BC/CA-3
and BC/CA-4 grafts. The in vitro CCK-8 assay indicates that the
BC/CA-2 graft has better biocompatibility than the BC/CA-3 and
BC/CA-4 grafts, as well as BC and CA grafts. Western blotting and
RT-qPCR results demonstrate promoted endothelialization of
the BC/CA-2 graft by upregulating expressions of genes vWF-1
and CD31 as well as protein CD31. In vivo results demonstrate
that the BC/CA-2 graft displays significantly better biocompatibility
than nanofibrous BC and submicrofibrous CA grafts. These
findings suggest that the BC/CA-2 graft shows a great potential as
a new type of vascular grafts. This study provides a new guideline
for the development of biomimetic vascular grafts.
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